{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:30:00Z","timestamp":1792593000251,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1111\/jth.15844","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T10:04:32Z","timestamp":1660212272000},"page":"2465-2474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["The NO\/cGMP\/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5673-1003","authenticated-orcid":false,"given":"Anisa","family":"Degjoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9290-874X","authenticated-orcid":false,"given":"Federica","family":"Campolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7420-301X","authenticated-orcid":false,"given":"Lucia","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0687-8135","authenticated-orcid":false,"given":"Mary Anna","family":"Venneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15844_bb0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/09537104.2020.1817360","article-title":"Immunothrombosis and thromboinflammation in host defense and disease","volume":"32","author":"Martinod","year":"2021","journal-title":"Platelets"},{"key":"10.1111\/jth.15844_bb0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1073\/pnas.98.1.355","article-title":"The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2","volume":"98","author":"Thomas","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15844_bb0020","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.3892\/mmr.2016.5005","article-title":"The cyclic AMP signaling pathway: exploring targets for successful drug discovery (Review)","volume":"13","author":"Yan","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1111\/jth.15844_bb0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1538-7836.2011.04576.x","article-title":"Novel roles of cAMP\/cGMP\u2010dependent signaling in platelets","volume":"10","author":"Smolenski","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15844_bb0030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ Res"},{"key":"10.1111\/jth.15844_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/801896","article-title":"Endothelium and its alterations in cardiovascular diseases: life style intervention","volume":"2014","author":"Favero","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1111\/jth.15844_bb0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/09537104.2018.1476681","article-title":"RAP GTPases and platelet integrin signaling","volume":"30","author":"Stefanini","year":"2019","journal-title":"Platelets"},{"key":"10.1111\/jth.15844_bb0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/ATVBAHA.107.150474","article-title":"Cell adhesion mechanisms in platelets","volume":"28","author":"Varga\u2010Szabo","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15844_bb0050","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood-2017-03-773614","article-title":"Integrin \u03b1(IIb)\u03b2(3) outside\u2010in signaling","volume":"130","author":"Durrant","year":"2017","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1111\/jth.15844_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1538-7836.2009.03401.x","article-title":"Dynamics of platelet thrombus formation","volume":"7","author":"Jackson","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15844_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/rth2.12061","article-title":"Platelets at the vascular interface","volume":"2","author":"Bergmeier","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.15844_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/ATVBAHA.120.314645","article-title":"Role of platelets in detection and regulation of infection","volume":"41","author":"Portier","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"210","key":"10.1111\/jth.15844_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-29423-5_1","article-title":"Platelets: production, morphology and ultrastructure","author":"Thon","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1111\/jth.15844_bb0075","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3389\/fimmu.2019.01805","article-title":"Platelets, thrombo\u2010inflammation, and cancer: collaborating with the enemy","volume":"10","author":"Palacios\u2010Acedo","year":"2019","journal-title":"Front Immunol"},{"key":"10.1111\/jth.15844_bb0080","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/eurheartj\/ehp296","article-title":"P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use","volume":"30","author":"Wallentin","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.15844_bb0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/pr.110.002907","article-title":"cGMP\u2010dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action","volume":"62","author":"Francis","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1111\/jth.15844_bb0090","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1476-5381.2011.01729.x","article-title":"Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments","volume":"165","author":"Keravis","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.15844_bb0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jcp.25880","article-title":"Identification of murine phosphodiesterase 5A isoforms and their functional characterization in HL\u20101 cardiac cell line","volume":"233","author":"Campolo","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1111\/jth.15844_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111311","article-title":"Type 5 phosphodiesterase (PDE5) and the vascular tree: from embryogenesis to aging and disease","volume":"190","author":"Cesarini","year":"2020","journal-title":"Mech Ageing Dev"},{"issue":"Suppl 1","key":"10.1111\/jth.15844_bb0105","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.ijir.3901207","article-title":"Tissue expression, distribution, and regulation of PDE5","volume":"16","author":"Lin","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1111\/jth.15844_bb0110","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/bph.14205","article-title":"PDE5 inhibitors \u2013 pharmacology and clinical applications 20\u2009years after sildenafil discovery","volume":"175","author":"Andersson","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.15844_bb0115","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase\u20105 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1111\/jth.15844_bb0120","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/13543784.2013.793672","article-title":"Targeting nitric oxide in the subacute restorative treatment of ischemic stroke","volume":"22","author":"Zhang","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1111\/jth.15844_bb0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/17425255.2017.1244265","article-title":"Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase\u20105 inhibitors","volume":"13","author":"Hong","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1111\/jth.15844_bb0130","doi-asserted-by":"crossref","first-page":"44584","DOI":"10.1038\/srep44584","article-title":"Phosphodiesterase\u20105 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR\u201022 and BMP7","volume":"7","author":"Pofi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1111\/jth.15844_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41443-018-0099-2","article-title":"Sildenafil\/Viagra in the treatment of premature ejaculation","volume":"31","author":"Krishnappa","year":"2019","journal-title":"Int J Impot Res"},{"key":"10.1111\/jth.15844_bb0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40618-015-0339-y","article-title":"Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask): how do they work?","volume":"39","author":"Pofi","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/jth.15844_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/andr.12837","article-title":"Targeting the NO\u2010cGMP\u2010PDE5 pathway in COVID\u201019 infection. The DEDALO project","volume":"9","author":"Isidori","year":"2021","journal-title":"Andrology"},{"key":"10.1111\/jth.15844_bb0150","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.coph.2021.08.007","article-title":"Priming metabolism with the type 5 phosphodiesterase: the role of cGMP\u2010hydrolyzing enzymes","volume":"60","author":"Campolo","year":"2021","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/jth.15844_bb0155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abl8503","article-title":"Sex\u2010specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double\u2010blind, placebo\u2010controlled trial","volume":"14","author":"Pofi","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1111\/jth.15844_bb0160","doi-asserted-by":"crossref","first-page":"15782","DOI":"10.1073\/pnas.1218880110","article-title":"Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide","volume":"110","author":"Kirkby","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15844_bb0165","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2125.2011.04034.x","article-title":"Anti\u2010platelet therapy: phosphodiesterase inhibitors","volume":"72","author":"Gresele","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jth.15844_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1538-7836.2007.02802.x","article-title":"Unresolved roles of platelet nitric oxide synthase","volume":"6","author":"Naseem","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15844_bb0175","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1096\/fasebj.3.9.2545495","article-title":"Endothelium\u2010derived relaxing and contracting factors","volume":"3","author":"Furchgott","year":"1989","journal-title":"FASEB J"},{"key":"10.1111\/jth.15844_bb0180","doi-asserted-by":"crossref","first-page":"C358","DOI":"10.1152\/ajpcell.90645.2007","article-title":"Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo","volume":"295","author":"Mizuno","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1111\/jth.15844_bb0185","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1073\/pnas.0408310102","article-title":"Regulation of platelet granule exocytosis by S\u2010nitrosylation","volume":"102","author":"Morrell","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15844_bb0190","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1021\/bi0620712","article-title":"S\u2010Nitrosylation of platelet alphaIIbbeta3 as revealed by Raman spectroscopy","volume":"46","author":"Walsh","year":"2007","journal-title":"Biochemistry"},{"key":"10.1111\/jth.15844_bb0195","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0031-6997(24)01457-1","article-title":"Guanylyl cyclases and signaling by cyclic GMP","volume":"52","author":"Lucas","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1111\/jth.15844_bb0200","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1160\/TH11-07-0461","article-title":"The thrombin inhibitors hirudin and Refludan(\u00ae) activate the soluble guanylyl cyclase and the cGMP pathway in washed human platelets","volume":"107","author":"Kobsar","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15844_bb0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10557-008-6098-7","article-title":"Platelet hyperaggregability: impaired responsiveness to nitric oxide (\"platelet NO resistance\") as a therapeutic target","volume":"22","author":"Rajendran","year":"2008","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1111\/jth.15844_bb0210","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cardiores.2007.05.021","article-title":"Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte\u2010platelet aggregates","volume":"75","author":"Goubareva","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1111\/jth.15844_bb0215","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.niox.2008.11.005","article-title":"Homocysteine decreases platelet NO level via protein kinase C activation","volume":"20","author":"Signorello","year":"2009","journal-title":"Nitric Oxide"},{"key":"10.1111\/jth.15844_bb0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1475-2840-11-5","article-title":"Platelet hyperaggregability in high\u2010fat fed rats: a role for intraplatelet reactive\u2010oxygen species production","volume":"11","author":"Monteiro","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1111\/jth.15844_bb0225","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/jth.15844_bb0230","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0005-2728(99)00024-9","article-title":"Guanylate cyclase and the .NO\/cGMP signaling pathway","volume":"1411","author":"Denninger","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/jth.15844_bb0235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/abbi.2001.2284","article-title":"Human soluble guanylate cyclase: functional expression, purification and structural characterization","volume":"388","author":"Kosarikov","year":"2001","journal-title":"Arch Biochem Biophys"},{"key":"10.1111\/jth.15844_bb0240","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.niox.2009.07.004","article-title":"The function of NO\u2010sensitive guanylyl cyclase: what we can learn from genetic mouse models","volume":"21","author":"Friebe","year":"2009","journal-title":"Nitric Oxide"},{"key":"10.1111\/jth.15844_bb0245","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme\u2010oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.15844_bb0250","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1073\/pnas.0609778104","article-title":"Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide\u2010sensitive guanylyl cyclase","volume":"104","author":"Friebe","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15844_bb0255","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/jth.15844_bb0260","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1002\/j.1460-2075.1996.tb01078.x","article-title":"Sensitizing soluble guanylyl cyclase to become a highly CO\u2010sensitive enzyme","volume":"15","author":"Friebe","year":"1996","journal-title":"EMBO J"},{"key":"10.1111\/jth.15844_bb0265","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjp.0704483","article-title":"Cardiovascular actions of a novel NO\u2010independent guanylyl cyclase stimulator, BAY 41\u20108543: in vivo studies","volume":"135","author":"Stasch","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.15844_bb0270","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0026-895X(25)10233-2","article-title":"Potent and selective inhibition of nitric oxide\u2010sensitive guanylyl cyclase by 1H\u2010[1,2,4]oxadiazolo[4,3\u2010a]quinoxalin\u20101\u2010one","volume":"48","author":"Garthwaite","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1111\/jth.15844_bb0275","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0162-0134(01)00387-7","article-title":"Role of conformational changes in the heme\u2010dependent regulation of human soluble guanylate cyclase","volume":"87","author":"Kosarikov","year":"2001","journal-title":"J Inorg Biochem"},{"key":"10.1111\/jth.15844_bb0280","doi-asserted-by":"crossref","first-page":"12938","DOI":"10.1073\/pnas.231486198","article-title":"YC\u20101 activation of human soluble guanylyl cyclase has both heme\u2010dependent and heme\u2010independent components","volume":"98","author":"Martin","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15844_bb0285","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1161\/01.ATV.0000249407.92147.12","article-title":"Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats","volume":"26","author":"Sch\u00e4fer","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15844_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047223","article-title":"Activation of haem\u2010oxidized soluble guanylyl cyclase with BAY 60\u20102770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway","volume":"7","author":"Mendes\u2010Silverio","year":"2012","journal-title":"PLoS One"},{"key":"10.1111\/jth.15844_bb0295","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1111\/bph.13286","article-title":"The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood","volume":"172","author":"Reiss","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.15844_bb0300","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.freeradbiomed.2010.10.714","article-title":"Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db\/Db diabetic mouse hind\u2010limb model by decreasing oxidative stress","volume":"50","author":"Pattillo","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1111\/jth.15844_bb0305","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/cvr\/cvq002","article-title":"Dipyridamole enhances ischaemia\u2010induced arteriogenesis through an endocrine nitrite\/nitric oxide\u2010dependent pathway","volume":"85","author":"Venkatesh","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1111\/jth.15844_bb0310","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00005344-200408000-00017","article-title":"Cilostazol and dipyridamole synergistically inhibit human platelet aggregation","volume":"44","author":"Liu","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/jth.15844_bb0315","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/j.1476-5381.2009.00631.x","article-title":"Thrombospondin\u20101 is an inhibitor of pharmacological activation of soluble guanylate cyclase","volume":"159","author":"Miller","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.15844_bb0320","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1182\/blood-2002-10-3210","article-title":"A predominant role for cAMP\u2010dependent protein kinase in the cGMP\u2010induced phosphorylation of vasodilator\u2010stimulated phosphoprotein and platelet inhibition in humans","volume":"101","author":"Li","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.15844_bb0325","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1182\/blood-2008-02-140970","article-title":"Src family tyrosine kinase Lyn mediates VWF\/GPIb\u2010IX\u2010induced platelet activation via the cGMP signaling pathway","volume":"112","author":"Yin","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.15844_bb0330","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1182\/blood-2011-06-362764","article-title":"Inflammation & the platelet histone trap","volume":"118","author":"Beaulieu","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.15844_bb0335","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1038\/s41467-018-06638-8","article-title":"A shear\u2010dependent NO\u2010cGMP\u2010cGKI cascade in platelets acts as an auto\u2010regulatory brake of thrombosis","volume":"9","author":"Wen","year":"2018","journal-title":"Nat Commun"},{"key":"10.1111\/jth.15844_bb0340","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/ATVBAHA.110.207522","article-title":"Signaling during platelet adhesion and activation","volume":"30","author":"Li","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15844_bb0345","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1182\/blood-2011-03-341107","article-title":"Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.15844_bb0350","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation","volume":"100","author":"Omori","year":"2007","journal-title":"Circ Res"},{"key":"10.1111\/jth.15844_bb0355","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.ijir.3900802","article-title":"Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters","volume":"14","author":"Lin","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1111\/jth.15844_bb0360","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/156802607779941198","article-title":"The novel functions of cGMP\u2010specific phosphodiesterase 5 and its inhibitors in carcinoma cells and pulmonary\/cardiovascular vessels","volume":"7","author":"Zhu","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1111\/jth.15844_bb0365","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0006-2952(01)00760-2","article-title":"Taming platelets with cyclic nucleotides","volume":"62","author":"Schwarz","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/jth.15844_bb0370","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2741\/1617","article-title":"NO\u2010sensitive guanylyl cyclase and NO\u2010induced feedback inhibition in cGMP signaling","volume":"10","author":"Mullershausen","year":"2005","journal-title":"Front Biosci"},{"key":"10.1111\/jth.15844_bb0375","first-page":"H448","article-title":"ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells","volume":"274","author":"Wyatt","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1111\/jth.15844_bb0380","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1074\/jbc.M106562200","article-title":"Regulation of cGMP\u2010specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells","volume":"277","author":"Rybalkin","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15844_bb0385","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0006-291X(63)90566-7","article-title":"Isolation of adenosine 3\u2032, 5\u2032\u2010monophosphate and guanosine 3\u2032, 5\u2032\u2010monophosphate from rat urine","volume":"11","author":"Ashman","year":"1963","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/jth.15844_bb0390","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/blood-2005-10-026294","article-title":"IRAG mediates NO\/cGMP\u2010dependent inhibition of platelet aggregation and thrombus formation","volume":"109","author":"Antl","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.15844_bb0395","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1182\/blood-2004-09-3605","article-title":"Rap1GAP2 is a new GTPase\u2010activating protein of Rap1 expressed in human platelets","volume":"105","author":"Schultess","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.15844_bb0400","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1160\/TH11-05-0319","article-title":"Differentiation of cGMP\u2010dependent and \u2010independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase","volume":"106","author":"Rukoyatkina","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15844_bb0405","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0026-895X(25)10974-7","article-title":"Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP","volume":"37","author":"Maurice","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1111\/jth.15844_bb0410","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-0037-1615861","article-title":"Cyclic nucleotides and phosphodiesterases in platelets","volume":"82","author":"Haslam","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15844_bb0415","doi-asserted-by":"crossref","first-page":"14964","DOI":"10.1016\/S0021-9258(18)77210-4","article-title":"Characterization of a purified bovine lung cGMP\u2010binding cGMP phosphodiesterase","volume":"265","author":"Thomas","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15844_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020612","article-title":"Mathematical modelling of nitric oxide\/cyclic GMP\/cyclic AMP signalling in platelets","volume":"19","author":"Kleppe","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1111\/jth.15844_bb0425","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/emboj\/18.1.37","article-title":"The vasodilator\u2010stimulated phosphoprotein (VASP) is involved in cGMP\u2010 and cAMP\u2010mediated inhibition of agonist\u2010induced platelet aggregation, but is dispensable for smooth muscle function","volume":"18","author":"Asz\u00f3di","year":"1999","journal-title":"EMBO J"},{"key":"10.1111\/jth.15844_bb0430","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbrc.2004.08.235","article-title":"Phosphorylation of mouse LASP\u20101 on threonine 156 by cAMP\u2010 and cGMP\u2010dependent protein kinase","volume":"324","author":"Keicher","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"191","key":"10.1111\/jth.15844_bb0435","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/978-3-540-68964-5_23","article-title":"cGMP and cGMP\u2010dependent protein kinase in platelets and blood cells","author":"Walter","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1111\/jth.15844_bb0440","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/01.RES.0000100390.68771.CC","article-title":"Cyclic GMP\u2010dependent protein kinases and the cardiovascular system: insights from genetically modified mice","volume":"93","author":"Feil","year":"2003","journal-title":"Circ Res"},{"key":"10.1111\/jth.15844_bb0445","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature12722","article-title":"Dysfunctional nitric oxide signalling increases risk of myocardial infarction","volume":"504","author":"Erdmann","year":"2013","journal-title":"Nature"},{"key":"10.1111\/jth.15844_bb0450","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.sxmr.2018.06.005","article-title":"The serendipitous story of sildenafil: an unexpected oral therapy for erectile dysfunction","volume":"7","author":"Goldstein","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1111\/jth.15844_bb0455","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0735-1097(02)02139-3","article-title":"The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia","volume":"40","author":"Halcox","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15844_bb0460","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1210\/jc.2018-02525","article-title":"PDE5 inhibition stimulates Tie2\u2010expressing monocytes and angiopoietin\u20101 restoring angiogenic homeostasis in diabetes","volume":"104","author":"Venneri","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/jth.15844_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126580","article-title":"Chronic inhibition of PDE5 limits pro\u2010inflammatory monocyte\u2010macrophage polarization in streptozotocin\u2010induced diabetic mice","volume":"10","author":"Venneri","year":"2015","journal-title":"PLoS One"},{"key":"10.1111\/jth.15844_bb0470","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1038\/s41598-019-44190-7","article-title":"Sildenafil reduces neointimal hyperplasia after angioplasty and inhibits platelet aggregation via activation of cGMP\u2010dependent protein kinase","volume":"9","author":"Yang","year":"2019","journal-title":"Sci Rep"},{"key":"10.1111\/jth.15844_bb0475","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10006-012-0387-9","article-title":"Sildenafil effect on prevention of thrombosis after microsurgical anastomosis: experimental rat model of thrombotic suture","volume":"18","author":"Pingarr\u00f3n\u2010Mart\u00edn","year":"2014","journal-title":"Oral Maxillofac Surg"},{"key":"10.1111\/jth.15844_bb0480","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004222","article-title":"Sildenafil is associated with reduced device thrombosis and ischemic stroke despite low\u2010level hemolysis on Heart Mate II support","volume":"10","author":"Saeed","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1111\/jth.15844_bb0485","first-page":"1264","article-title":"Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction","volume":"103","author":"Andersson","year":"2017","journal-title":"Heart (British Cardiac Society)"},{"key":"10.1111\/jth.15844_bb0490","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM200006013422201","article-title":"Hemodynamic effects of sildenafil in men with severe coronary artery disease","volume":"342","author":"Herrmann","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15844_bb0495","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jchf.2021.09.008","article-title":"Postimplant phosphodiesterase\u20105 inhibitor use in centrifugal flow left ventricular assist devices","volume":"10","author":"Xanthopoulos","year":"2022","journal-title":"JACC Heart failure"},{"key":"10.1111\/jth.15844_bb0500","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jacc.2005.11.060","article-title":"Sildenafil improves coronary artery patency in a canine model of platelet\u2010mediated cyclic coronary occlusion after thrombolysis","volume":"47","author":"Lewis","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1111\/jth.15844_bb0505","first-page":"61s","article-title":"Onset and duration of action of sildenafil for the treatment of erectile dysfunction","volume":"53","author":"Eardley","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jth.15844_bb0510","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/0003319710362977","article-title":"Effects of tadalafil on platelets and endothelium in patients with erectile dysfunction and cardiovascular risk factors: a pilot study","volume":"61","author":"De Bon","year":"2010","journal-title":"Angiology"},{"key":"10.1111\/jth.15844_bb0515","doi-asserted-by":"crossref","DOI":"10.1111\/and.13347","article-title":"The effect of using tadalafil 5 mg\/day on neutrophil\u2010lymphocyte and platelet\u2010lymphocyte ratios in mild\u2010medium and severe erectile dysfunction patients; and comparison of clinical response","volume":"51","author":"Demirci","year":"2019","journal-title":"Andrologia"},{"key":"10.1111\/jth.15844_bb0520","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/bjp.2008.141","article-title":"Vardenafil, but not sildenafil or tadalafil, has calcium\u2010channel blocking activity in rabbit isolated pulmonary artery and human washed platelets","volume":"154","author":"Toque","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.15844_bb0525","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bcp.2017.08.026","article-title":"Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human platelets","volume":"145","author":"Bajraktari","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/jth.15844_bb0530","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbrc.2005.09.060","article-title":"Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation","volume":"337","author":"Gudmundsd\u00f3ttir","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/jth.15844_bb0535","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cellsig.2004.07.007","article-title":"The effect of sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5","volume":"17","author":"Dunkern","year":"2005","journal-title":"Cell Signal"},{"key":"10.1111\/jth.15844_bb0540","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4081\/aiua.2021.2.221","article-title":"A new original nutraceutical formulation ameliorates the effect of Tadalafil on clinical score and cGMP accumulation","volume":"93","author":"Mirone","year":"2021","journal-title":"Arch Ital Urol Androl"},{"key":"10.1111\/jth.15844_bb0545","first-page":"44","article-title":"Moringa oleifera Lam.: protease activity against blood coagulation cascade","volume":"4","author":"Satish","year":"2012","journal-title":"Pharm Res"},{"key":"10.1111\/jth.15844_bb0550","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/jcb.23008","article-title":"The anandamide effect on NO\/cGMP pathway in human platelets","volume":"112","author":"Signorello","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1111\/jth.15844_bb0555","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1111\/bph.14920","article-title":"Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease","volume":"177","author":"Tzoumas","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.15844_bb0560","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(17)32849-0","article-title":"Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open\u2010label, phase 3 superiority trial","volume":"391","author":"Bath","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1111\/jth.15844_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225771","article-title":"Gender\u2010based differences in platelet function and platelet reactivity to P2Y12 inhibitors","volume":"14","author":"Ranucci","year":"2019","journal-title":"PLoS One"},{"key":"10.1111\/jth.15844_bb0570","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/1440-1681.12589","article-title":"Platelet hyperaggregability in obesity: is there a role for nitric oxide impairment and oxidative stress?","volume":"43","author":"Leite","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1111\/jth.15844_bb0575","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nm810","article-title":"Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E","volume":"9","author":"Huo","year":"2003","journal-title":"Nat Med"},{"key":"10.1111\/jth.15844_bb0580","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/eurheartj\/ehab631","article-title":"Matrix metalloproteinase\u20102 on activated platelets triggers endothelial PAR\u20101 initiating atherosclerosis","volume":"43","author":"Momi","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.15844_bb0585","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15844_bb0590","article-title":"Inhibition of phosphodiesterase 3A by cilostazol dampens proinflammatory platelet functions","volume":"10","author":"Coenen","year":"2021","journal-title":"Cell"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15844","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15844","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622184746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622184746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:35:24Z","timestamp":1761536124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622184746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":117,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1538783622184746"],"URL":"https:\/\/doi.org\/10.1111\/jth.15844","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The NO\/cGMP\/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}